|
Volumn 9, Issue 10, 2003, Pages 667-
|
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
DOXORUBICIN;
ETOPOSIDE;
PREDNISONE;
VINCRISTINE;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
AUTOTRANSPLANTATION;
B CELL LYMPHOMA;
CANCER RECURRENCE;
CANCER REGRESSION;
CLINICAL PRACTICE;
EVIDENCE BASED MEDICINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HIGH RISK PATIENT;
HUMAN;
INTERMETHOD COMPARISON;
LARGE CELL LYMPHOMA;
NONHODGKIN LYMPHOMA;
NOTE;
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;
PRACTICE GUIDELINE;
RECURRENCE RISK;
STANDARDIZATION;
STEM CELL MOBILIZATION;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
|
EID: 1542682276
PISSN: 10838791
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bbmt.2003.09.012 Document Type: Article |
Times cited : (8)
|
References (0)
|